Price $22.14 |
Market Cap
169.2M
|
Sector Health Care |
Div. Growth
-
|
|
P/E
8.7
|
P/B
1.71
|
P/S
2.07
|
Dividend %
-
|
|
P/CF
18.1
|
P/FCF
10.9
|
Op. Cash Flow
18.7K
|
FCF
2.3
|
|
Op. Margin
24.10%
|
Net Margin
24.40%
|
ROE
22.50%
|
ROI
25.60%
|
|
ROA
18.50%
|
EPS Growth
6.30%
|
Current Ratio
4.6
|
Debt/Equity
0.30%
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Harvard Bioscience, Inc. (HBIO) | $3.56 | - | - | 146.7M | Strong Buy |
| Mentor Capital Inc (MNTR) | $0.63 | - | - | 15.4M | Strong Buy |
| Cardiovascular Systems Inc (CSII) | $30.23 | - | - | 1.02B | Strong Buy |
| Champions Oncology Inc (CSBR) | $10.35 | - | - | 142.1M | Strong Buy |
| Navidea Biopharmaceuticals Inc (NAVB) | $0.19 | - | - | 40.1M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
